Cancer-Targetable pH-Sensitive Zinc-Based Immunomodulators Combined with Photodynamic Therapy for in Situ Vaccination

Area of Science:

• Biomedical Engineering
• Cancer Research
• Immunotherapy

Background:

• Cancer vaccines show promise but face challenges due to tumor heterogeneity and costly antigen screening.
• Individualized cancer vaccines are hindered by the time and expense of identifying tumor-associated antigens (TAAs).

Purpose of the Study:

• To develop an in situ vaccination strategy using cancer-targetable pH-sensitive zinc-based immunomodulators (CZIs).
• To elicit an antitumor immune response against patient-specific TAAs without ex vivo identification.
• To overcome the limitations of current cancer vaccine development.

Main Methods:

• Utilized cancer-targetable pH-sensitive zinc-based immunomodulators (CZIs) for in situ vaccination.
• Investigated the combined effects of zinc ions and photodynamic therapy (PDT) within the tumor microenvironment.
• Evaluated the efficacy in CT26 tumor-bearing mice, assessing tumor growth and lung metastasis.

Main Results:

• CZIs promoted TAA release and calreticulin exposure via immunogenic cell death.
• The treatment effectively inhibited tumor growth and reduced lung metastasis in vivo.
• Demonstrated potentiation of antitumor immunity through the novel nanoplatform.

Conclusions:

• The proposed in situ vaccination strategy using CZIs offers an alternative to traditional cancer vaccines.
• This approach circumvents the need for ex vivo TAA identification, addressing key development hurdles.
• The nanoplatform holds potential for broadening the application of nanoparticles in cancer immunotherapy.